Paola Zanovello

Paola Zanovello

orcid

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
VBVincenzo Bronte
Vincenzo Bronte
PZPaola Zanovello
Paola Zanovello

1 June 2010 in Immunity
Verified
Journal Article
Closed access
IMIlaria Marigo
Ilaria Marigo
EBErika Bosio
Erika Bosio
SSSamantha Solito
Samantha Solito
CMCirce Mesa
Circe Mesa
AFAudry Fernandez
Audry Fernandez
VBVincenzo Bronte
Vincenzo Bronte

2 October 2006 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
GGGiovanna Gallina
Giovanna Gallina
LDLuigi Dolcetti
Luigi Dolcetti
PSPaolo Serafini
Paolo Serafini
CSC. D. Santo
C. D. Santo
IMIlaria Marigo
Ilaria Marigo
VBVincenzo Bronte
Vincenzo Bronte
Active suppression of tumor-specific T lymphocytes can limit the efficacy of immune surveillance and immunotherapy. While tumor-recruited CD11b+ myeloid cells are known mediators of tumor-associated immune dysfunction, the true nature of these suppressive cells and the fine biochemical pathways governing their immunosuppressive activity remain elusive. Here we describe a population of circulating CD11b+IL-4 receptor α+ (CD11b+IL-4Rα+), inflammatory-type monocytes that is elicited by growing tumors and activated by IFN-γ released from T lymphocytes. CD11b+IL-4Rα+ cells produced IL-13 and IFN-γ and integrated the downstream signals of these cytokines to trigger the molecular pathways suppressing antigen-activated CD8+ T lymphocytes. Analogous immunosuppressive circuits were active in CD11b+ cells present within the tumor microenvironment. These suppressor cells challenge the current idea that tumor-conditioned immunosuppressive monocytes/macrophages are alternatively activated. Moreover, our data show how the inflammatory response elicited by tumors had detrimental effects on the adaptive immune system and suggest novel approaches for the treatment of tumor-induced immune dysfunctions.

15 January 2002 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
AMAlessandra Mazzoni
Alessandra Mazzoni
VBVincenzo Bronte
Vincenzo Bronte
AVAlberto Visintin
Alberto Visintin
JSJessica H. Spitzer
Jessica H. Spitzer
EAElisa Apolloni
Elisa Apolloni
DSDavid M. Segal
David M. Segal
CD11b+Gr-1+ myeloid suppressor cells (MSC) accumulate in lymphoid organs under conditions of intense immune stress where they inhibit T and B cell function. We recently described the generation of immortalized MSC lines that provide a homogeneous source of suppressor cells for dissecting the mechanism of suppression. In this study we show that the MSC lines potently block in vitro proliferation of T cells stimulated with either mitogen or antigenic peptide, with as few as 3% of MSC cells causing complete suppression. Inhibition of mitogenic and peptide-specific responses is not associated with a loss in IL-2 production or inability to up-modulate the early activation markers, CD69 and CD25, but results in direct impairment of the three IL-2R signaling pathways, as demonstrated by the lack of Janus kinase 3, STAT5, extracellular signal-regulated kinase, and Akt phosphorylation in response to IL-2. Suppression is mediated by and requires NO, which is secreted by MSC in response to signals from activated T cells, including IFN-γ and a contact-dependent stimulus. Experiments with inducible NO synthase knockout mice demonstrated that the inhibition of T cell proliferation by CD11b+Gr-1+ cells in the spleens of immunosuppressed mice is also dependent upon NO, indicating that the MSC lines accurately represent their normal counterparts. The distinctive capacity of MSC to generate suppressive signals when encountering activated T cells defines a specialized subset of myeloid cells that most likely serve a regulatory function during times of heightened immune activity.

1 April 2010 in Current Opinion in Immunology
Verified
Journal Article
Closed access
EPElisa Peranzoni
Elisa Peranzoni
SZSerena Zilio
Serena Zilio
IMIlaria Marigo
Ilaria Marigo
LDLuigi Dolcetti
Luigi Dolcetti
PZPaola Zanovello
Paola Zanovello
VBVincenzo Bronte
Vincenzo Bronte

19 March 2008 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
IMIlaria Marigo
Ilaria Marigo
LDLuigi Dolcetti
Luigi Dolcetti
PSPaolo Serafini
Paolo Serafini
PZPaola Zanovello
Paola Zanovello
VBVincenzo Bronte
Vincenzo Bronte